Reduced Proteasomal Activity in Marrow Cells From Myelodysplastic Syndrome (MDS) Patients.

被引:0
作者
Karabina, Stela [1 ]
Thanopoulou, Eleni [1 ]
Athanasiou, Sotirios D. [2 ]
Symeonidis, Argiris [3 ]
Zoumbos, Nicholas [4 ]
机构
[1] Univ Patras, Sch Med, Div Hematol, Dept Internal Med, Patras, Greece
[2] Univ Patras, Dept Chem, Biochem Lab, Patras, Greece
[3] Univ Patras, Sch Med, GR-26110 Patras, Greece
[4] Univ Patras, Rion, Greece
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:706 / 707
页数:2
相关论文
共 50 条
  • [31] Dynamics of the apoptotic death of bone marrow cells in myelodysplastic syndromes (MDS).
    Mundle, S
    Cartlidge, J
    Venugopal, P
    Gezer, S
    Hines, C
    Jassak, P
    Gregory, SA
    Alvi, S
    Shetty, V
    Robin, E
    Kawauchi, R
    Rifkin, S
    Alston, D
    Hernandez, B
    Shah, R
    Raza, A
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 309 - 309
  • [32] Simultaneous detection of granulocyte abnormalities in blood and bone marrow of patients with myelodysplastic syndrome (MDS) by flow cytometry
    Beck, RC
    Maciejewski, JP
    Stahl, S
    Hsi, ED
    LABORATORY INVESTIGATION, 2005, 85 : 223A - 224A
  • [33] Simultaneous detection of granulocyte abnormalities in blood and bone marrow of patients with myelodysplastic syndrome (MDS) by flow cytometry
    Beck, RC
    Maciejewski, JP
    Stahl, S
    Hsi, ED
    MODERN PATHOLOGY, 2005, 18 : 223A - 224A
  • [34] Homoharringtonine in patients with myelodysplastic syndrome (MDS) and MDS evolving to acute myeloid leukemia
    Feldman, EJ
    Seiter, KP
    Ahmed, T
    Baskind, P
    Arlin, ZA
    LEUKEMIA, 1996, 10 (01) : 40 - 42
  • [35] Improved growth of stromal cells in long term bone marrow cultures (LTBMC) of myelodysplastic syndrome (MDS) patients treated with thalidomide.
    Alvi, S
    Shaher, A
    Henderson, B
    Dar, S
    Zorat, F
    Broderick, E
    Lisak, L
    Du Randt, M
    Reddy, P
    Mundle, S
    Galili, N
    Borok, RZ
    Raza, A
    BLOOD, 2000, 96 (11) : 359A - 359A
  • [36] Activity of Venetoclax-Based Therapy in Myelodysplastic Syndrome (MDS)
    Cortes, Jorge
    Garcia-Manero, Guillermo
    Sasaki, Koji
    Naqvi, Kiran
    Alvarado, Yesid
    Kadia, Tapan M.
    Ravandi, Farhad
    Cortes, Jorge E.
    Daver, Naval G.
    Takahashi, Koichi
    Jabbour, Elias
    Borthakur, Gautam M.
    Pemmaraju, Naveen
    Konopleva, Marina Y.
    Pierce, Sherry A.
    Bueso-Ramos, Carlos E.
    Patel, Keyur P.
    Kantarjian, Hagop M.
    Bravo, Guillermo Montalban
    BLOOD, 2019, 134
  • [37] Decreased level of Smad mRNAs in bone marrow mononuclear cells of some patients with myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML).
    Fuchs, O
    BLOOD, 2003, 102 (11) : 186B - 186B
  • [38] In Vivo Production of Cytokines by Bone Marrow Stromal Cells and Macrophages from Patients with Myelodysplastic Syndrome
    T. E. Manakova
    N. V. Tsvetaeva
    A. A. Levina
    K. S. Momotyuk
    G. P. Sarkisyan
    N. D. Khoroshko
    L. P. Gerasimova
    Bulletin of Experimental Biology and Medicine, 2001, 132 : 633 - 636
  • [39] In vivo production of cytokines by bone marrow stromal cells and macrophages from patients with myelodysplastic syndrome
    Manakova, TE
    Tsvetaeva, NV
    Levina, AA
    Momotyuk, KS
    Sarkisyan, GP
    Khoroshko, ND
    Gerasimova, LP
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2001, 132 (01) : 633 - 636
  • [40] Allogeneic marrow transplantation (BMT) for the treatment of myelodysplastic syndrome (MDS) in children.
    Boulad, F
    Small, TN
    Kernan, NA
    George, D
    Prasad, V
    Regan, AD
    Torok-Castanza, J
    Heller, G
    O'Reilly, RJ
    Castro-Malaspina, H
    BLOOD, 1999, 94 (10) : 562A - 562A